PPD
$35.579876543210-$,.9876543210-$,.9876543210-$,.9876543210-$,.9876543210-$,.9876543210-$,.9876543210-$,.
$35.57
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
-$0.29 (-0.81%) As of 3:22 PM UTC today
Why Robinhood?
You can buy or sell PPD and other stocks, options, and ETFs commission-free!
About PPD
PPD, Inc. provides drug development services to the biopharmaceutical industry, focuses on helping customers bring their new medicines to patients around the world. The firm also provides clinical development and laboratory services to pharmaceutical, biotechnology, medical device and government organizations and other industry participants. Its clinical development services include all phases of development (Phase I-IV), peri- and post-approval and site and patient access services; laboratory services offers advanced testing services, including bioanalytical, biomarker, vaccine, good manufacturing practice and central laboratory services. The company was founded by Fred Eshelma in 1985 and is headquartered in Wilmington, NC. The listed name for PPD is PPD, Inc. Common Stock.
CEO
David S. Simmons
Employees
23,000
Headquarters
Wilmington, North Carolina
Founded
1985
Market Cap
12.68B
Price-Earnings Ratio
235.24
Dividend Yield
—
Average Volume
740.80K
High Today
$36.06
Low Today
$35.55
Open Price
$35.92
Volume
69.57K
52 Week High
$37.51
52 Week Low
$10.61
Collections
Analyst Ratings
94%
of 17 ratings
Buy
94%
Hold
6%
Sell
0%
PPD Earnings
$0.00
$0.11
$0.22
$0.33
Q4 FY19
Q1 FY20
Q2 FY20
Q3 FY20
Q4 FY20
Estimated
— per share
Actual
Expected Mar 3, After Hours